Antimicrobial and antiviral screening of novel indole carboxamide and propanamide derivatives

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 63, Issue 3-4, 2008, Pages 189-195

  Ölgen, Süreyya ^a   Altanlar, Nurten ^a   Karatayli, Ersin ^a   Bozdayi, Mithat ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Antibacterial and antifungal activity; Indole derivatives; Inhibition of HBV

Indexed keywords

BACILLUS SUBTILIS; CANDIDA ALBICANS; ESCHERICHIA COLI; HEPATITIS B VIRUS; STAPHYLOCOCCUS AUREUS;

EID: 49649090629     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2008-3-405     Document Type: Article

References (30)

1. Beaulieu P. L., Gillard J., Bykowski D., Brochu C., Dansereau N., Duceppe J.-S., Hache B., Jakalian A., Lagace L., La Plante S., Mcercher G., Moreau E., Perreault S., Stammers T., Thauvette L., Warrington J., and Kukolj G. (2006), Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: From benzimidazole to indole scaffolds. Bioorg. Med. Chem. Lett. 16, 4987-4993.
2. Bhovi M. G. and Gadaginamath G. S. (2005), 1,3-Dipolar cycloaddition reactions: Synthesis and antimicrobial activity of novel 1-triazolylindole and 1-triazolylbenz-[g]indole derivatives. Indian J. Chem. 44B, 1068-1073.
3. Borgia G. and Gentile I. (2006), Treating chronic hepatitis B: today and tomorrow. Curr. Med. Chem. 13, 2839-2855.
4. Bozkaya H., Yurdaydin C., and Idilman R. (2005), Lamivudine treatment in HBeAg-negative chronic hepatitis B patients with low level viraemia. Antiviral Ther. 10, 319-325.
5. Bozkaya P., Olgen S., Çoban T., and Nebioǧlu D. (2007), Synthesis of N-substituted indole-2-carboxamides and investigation of their biochemical responses against free radicals. J. Enzym. Inhib. Med. Chem. 22, 319-325.
6. Conte I., Ercolani C., Narjes F., Pompei M., Rowley M., and Stansfield I. (2006), Preparation of tetracyclic indole derivatives as antiviral agents. Patent WO 2006046030.
7. Delaney W. E., Edwards R., Colledge D., Shaw T., Furman P., Painter G., and Locarnini S. (2002), Phenylpropanamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistance strains of hepatitis B virus in vitro. Antimicrob. Agents Chemother. 46, 3057-3060.
8. Donawade D. S. and Gadaginamath G. S. (2005), Some electrophilic substitution reactions on 1-substituted-3-acetyl/carbethoxy-5-hydroxy-2- methylindole and antimicrobial activity of these new indole derivatives. Indian J. Chem. 44B, 1679-1685.
9. Gadaginamath G. S. and Kavali R. R. (1999), Synthesis and antimicrobial activity of novel 4H-pyrano[2,3-f]-indole derivatives. Indian J. Chem. 38B, 178-182.
10. Harper S., Avolio S., Pacini B., Di Filippo M., Altamura S., Tomei L., Paonessa G., Di Marco S., Carfi A., Giuliano C., Padron J., Bonelli F., Migliaccio G., De Francesco R., Laufer R., Rowley M., and Narjes F. (2005), Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymerase. J. Med. Chem. 48, 4547-4557.
11. Jiang T., Kuhen K. L., Wolff K., Yin H., Bieza K., Caldwell J., Bursulaya B., Tuntland T., Zhang K., Karanewsky D., and He Y. (2006), Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorg. Med. Chem. Lett. 16, 2109-2112.
12. Macchia M., Manera C., Nencetti S., Rossello A., Broccali G., and Limonta D. (1996), Synthesis and anti-microbial activity of benzo[a]dihydrocarbazole and benzotetrahydrocyclohept[1,2-b]indole derivatives. Farmaco 51, 75-78.
13. Malesani G., Chiarelotto G., Dallacqua E., and Vedali D. (1975), Antimicrobial properties of some 3-acyl-4,7-disubstituted indoles. Farmaco 30, 137-146.
14. Mehta A., Carrouee S., Conyers B., Jordan R., Butters T., Dwek R. A., and Block T. M. (2001), Inhibition of hepatitis B virus DNA replication by iminosugar without the inhibition of the DNA polymerase: therapeutic implications. Hepatology 33, 1488-1495.
15. Mehta D. S., Sikotra K. H., and Shah V. H. (2005), Synthesis and biological screening of some new novel indole derivatives. Indian J. Chem. 44B, 2590-2597.
16. Ölgen S., Kihç Z., Ada A. O., and Çoban T. (2007a), Synthesis and antioxidant properties of novel N-H and N-substituted propanamide derivatives. Arch. Pharm. 340, 140-146.
17. Ölgen S., Kiliç Z., Ada A. O., and Çoban T. (2007b), Synthesis and evaluation of novel N-H and N-substituted indole-2- and -3-carboxamide derivatives as possible antioxidant agents. J. Enzym. Inhib. Med. Chem. 22, 457-462.
18. Romero D. L., Olmsted R. A., Poel T. J., Morge R. A., Biles C., Keiser B. J., Kopta L. A., Friis J. M., Hosley J. D., Stefanski K. J., Wishka D. G., Evans D. B., Morris J., Stehle R. G., Sharma S. K., Yagi Y., Voorman R. L., Adams W. J., and Tarpley W. G. (1996), Delaviridine/ateviridine resistance HIV-1. 2. Identification of (alkylamino)piperidine-containing bis(heteroaryl)piperazines as broad spectrum reverse transcriptase inhibitors. J. Med. Chem. 39, 3769-3789.
19. Slater M. J., Baxter R., Bonser R. W., Cockerill S., Gohil K., Robinson E., Randall R., Yeates C., Snowden W., and Walters A. (2001), Synthesis of N-alkyl substituted indolocarbazoles as potent inhibitors of human cytomegalovirus replication. Bioorg. Med. Chem. Lett. 11, 1993-1995.
20. Tan T. M. C., Chen Y., Kong H., Bai J., Li Y., Lim S. G., Ang T. H., and Lam Y. (2006), Synthesis and the bio-logical evaluation of 2- benzenesulfonylalkyl-5-substituted-sulfonyl-[1,3,4]-oxadiazoles as potential antihepatitis B virus agents. Antiviral Res. 71, 7-14.
21. Tsotinis A., Varvaresou A., Calogeropoulou T., Siatra-Papastaikoudi T., and Tiligada A. (1997), Synthesis and antimicrobial evaluation of indole containing derivatives of 1,3,4-triazole and their open-chain counterparts. Arzneim.-Forsch./Drug Res. 47, 307-310.
22. Tunçbilek M. and Altanlar N. (2006), Synthesis of new 3-(substituted phenacyl)-5-[3′-(4H-4-oxo-1-benzopyran-2-yl)- benzylidene]-2,4-thiazolidinediones and their antimicrobial activity. Arch. Pharm. Chem. Life Sci. 339, 213-216.
23. Tunçbilek M., Bozdaǧ O., Ayhan-Kilcigil G., Altanlar N., Büyükbingöl E., and Ertan R. (1999), Synthesis and antimicrobial activity of some new flavonyl oxime ether derivatives. Arzneim.-Forsch./Drug Res. 49, 853-857.
24. Varvaresou A., Tsantili-Kakoulidou A., Siatra-Papastaikoudi T., and Tiligada E. (2000), Synthesis and biological evaluation of indole containing derivatives of thiosemicarbazide and their cyclic 1,2,4-triazole and 1,3,4-thiadiazole analogs. Arzneim.-Forsch./Drug Res. 50, 48-54.
25. Weber O., Schlemmer K. H., Hartmann E., Hagelschuer I., Paessens A., Graef E., Deres K., Goldmann S., Niewoehner U., Stoltefuss J., Haebich D., Ruebsamen-Waigmann H., and Wohlfeil S. (2002), Inhibition of human hepatitis B virus (HBV) by a novel non-nucleoside compound in a transgenic mouse model. Antiviral Res. 54, 68-78.
26. Wen Y.-M., Lin X., and Ma Z.-M. (2003), Exploring new potential targets for anti-hepatitis B virus drugs. Curr. Drug Targets 3, 241-246.
27. Whitehead C. W. and Whitesitt A. A. (1974), Effects of lipophilic substituents on some biological properties of indoles. J. Med. Chem. 17, 1298-1304.
28. Williams T. M., Ciccarone T. M., MacTough S. C., Rooney C. S., Balani S. K., Condra J. H., Emini E. A., Goldman M. E., Greenlee W. J., Kauffman L. R., O'Brien W. J., Sardana V. V., Schleif W. A., Theoharides A. D., and Anderson P. S. (1993), 5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: A novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase. J. Med. Chem. 36, 1291-1294.
29. Ying C., De Clercq E., and Neyts J. (2003), Selective inhibitors of hepatitis B virus replication. Curr. Med. Chem. 2, 227-240.
30. Zhao Y., Hong W., Chai H., Dong J., and Gong P. (2004), Synthesis and anti-influenza virus activity of ethyl-6-bromo-5-hydroxy-1H-indole-3- carboxylate derivatives. Zhongguo Yaowu Huaxue Zazhi 14, 219-224.